A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma
Clinical trial NCT07010497 · RECRUITING
Trial details
- NCT number
- NCT07010497
- Sponsor
- Asan Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-16
- Primary completion
- 2029-03-31
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.